Zhengye Biotechnology's Fiscal Year 2024 Financial Results Highlight Strategic Shifts and Future Growth Potential Zhengye Biotechnology reports its fiscal year 2024 results, showcasing significant market adaptations and future growth strategies in veterinary vaccines.

Zhengye Biotechnology's Fiscal Year 2024 Financial Results Highlight Strategic Shifts and Future Growth Potential #China #Veterinary_Vaccines #Jilin #Zhengye_Biotech #Nasdaq_ZYBT